Drug intelligence / Profile preview

dehydroepiandrosterone sulfate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intravenous, Topical
01

Overview

Dehydroepiandrosterone sulfate is an endogenous steroid hormone produced primarily by the adrenal cortex and is the 3β-sulfate ester form and major circulating metabolite of dehydroepiandrosterone (DHEA)[1][7]. DHEA-S is hormonally inert but acts as a neurosteroid and neurotrophin, influencing several neurotransmitter systems. It is a positive allosteric modulator of the NMDA receptor, a negative allosteric modulator of GABA_A and glycine receptors, a weak agonist of the sigma-1 receptor, and binds to TrkA and p75^NTR^ (neurotrophin receptors) with high affinity[1]. DHEA-S can inhibit TRPV1 and TRPC5 channels and P2X receptors[1]. Clinically, prasterone sodium sulfate (the sodium salt form of DHEA-S) is approved in Japan for cervical ripening and dilation during childbirth[1]. DHEA supplementation or DHEA-S testing is used in evaluating adrenal function, androgen excess, disorders of sexual development, and early/late puberty[5][9]. DHEA-S may be used off-label or investigationally for conditions such as systemic lupus erythematosus (SLE), adrenal insufficiency, depression, osteoporosis, and sexual dysfunction, but efficacy and long-term safety remain inadequately established[2][3][4][6][8][10].

Brand names
prasterone sodium sulfate
Other names
androstenolone sulfatedehydroepiandrosterone-3-sulfatedehydroepiandrosterone3-sulfatedehydroepiandrosterone 3-sulfate
02

Targets

SIGMAR1 (Sigma non-opioid intracellular receptor 1)GABAA (Gamma-aminobutyric acid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on dehydroepiandrosterone sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dehydroepiandrosterone sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call